Onset of Action of Single Doses of Formoterol Administered via Turbuhaler in Patients with Stable COPD
- 31 January 2001
- journal article
- clinical trial
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 14 (1) , 41-45
- https://doi.org/10.1006/pupt.2000.0267
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Long-Acting ??2 Agonists in the Management of Stable Chronic Obstructive Pulmonary DiseaseDrugs, 2000
- Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPDEuropean Respiratory Journal, 1998
- Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstructionEuropean Respiratory Journal, 1997
- The Use of Bronchodilators in Stable Chronic Obstructive Pulmonary DiseasePulmonary Pharmacology & Therapeutics, 1997
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response studyRespiratory Medicine, 1995
- Why are long-acting beta-adrenoceptor agonists long-acting?European Respiratory Journal, 1994
- Formoterol: Pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilatorLife Sciences, 1993
- Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.Thorax, 1993